Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 12/20 | 0.74 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.60 |
| ▸ | CNR1 | P21554 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | HTR2C | P28335 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8961102 | 0.97 | MTNR1A (0.69) | MTNR1AMTNR1BKDM4EHPGDHSD17B10 | |
| SCHEMBL8961006 | 0.93 | MTNR1A (0.71) | MTNR1AMTNR1BKDM4EHSD17B10HTR2C | |
| SCHEMBL8961114 | 0.89 | MTNR1A (0.73) | MTNR1AMTNR1B | |
| SCHEMBL8961137 | 0.88 | MTNR1A (0.72) | MTNR1AMTNR1BCNR1KDM4EHPGD | |
| SCHEMBL8961193 | 0.88 | MTNR1A (0.76) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL8961204 | 0.87 | MTNR1A (0.66) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL8960897 | 0.86 | MTNR1A (0.74) | MTNR1AMTNR1BKDM4EHPGDHSD17B10 | |
| SCHEMBL8961320 | 0.85 | MTNR1A (0.67) | MTNR1AMTNR1BKDM4EHPGDHSD17B10 | |
| SCHEMBL8960796 | 0.84 | MTNR1A (0.71) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL6258031 | 0.84 | MTNR1A (0.84) | MTNR1AMTNR1BHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5552418-A | FOR TREATING DISORDERS OF THE MELATONINERGIC SYSTEM | ADIR ET COMPAGNIE (FR) | 1996-09-03 | — | — | US | disclosed |